• Trade
  • Markets
  • Copy
  • Contests
  • News
  • 24/7
  • Calendar
  • Q&A
  • Chats
Screeners
SYMBOL
LAST
ASK
BID
HIGH
LOW
NET CHG.
%CHG.
SPREAD
SPX
S&P 500 Index
6798.39
6798.39
6798.39
6857.86
6780.45
-84.33
-1.23%
--
DJI
Dow Jones Industrial Average
48908.71
48908.71
48908.71
49340.90
48829.10
-592.58
-1.20%
--
IXIC
NASDAQ Composite Index
22540.58
22540.58
22540.58
22841.28
22461.14
-363.99
-1.59%
--
USDX
US Dollar Index
97.690
97.770
97.690
97.790
97.600
-0.130
-0.13%
--
EURUSD
Euro / US Dollar
1.17911
1.17918
1.17911
1.18014
1.17655
+0.00123
+ 0.10%
--
GBPUSD
Pound Sterling / US Dollar
1.35651
1.35660
1.35651
1.35782
1.35081
+0.00347
+ 0.26%
--
XAUUSD
Gold / US Dollar
4856.13
4856.54
4856.13
4903.14
4655.10
+78.24
+ 1.64%
--
WTI
Light Sweet Crude Oil
63.806
63.836
63.806
64.128
62.146
+0.872
+ 1.39%
--

Community Accounts

Signal Accounts
--
Profit Accounts
--
Loss Accounts
--
View More

Become a signal provider

Sell trading signals to earn additional income

View More

Guide to Copy Trading

Get started with ease and confidence

View More

Signal Accounts for Members

All Signal Accounts

Best Return
  • Best Return
  • Best P/L
  • Best MDD
Past 1W
  • Past 1W
  • Past 1M
  • Past 1Y

All Contests

  • All
  • Trump Updates
  • Recommend
  • Stocks
  • Cryptocurrencies
  • Central Banks
  • Featured News
Top News Only
Share

HKMA - Hong Kong Forex Reserves At $435.6 Billion At End-Jan

Share

European Central Bank Governing Council Member Rehn: Any Changes In The Key Interest Rates In The Future, If Justified, Are Not Excluded

Share

European Central Bank Governing Council Member Rehn: We Must All Be Prepared For The Fact That Geopolitical Developments May Still Bring New Surprises, We Must Be Ready To React To Them

Share

European Central Bank Governing Council Member Rehn: At Our Next Meeting In March, We Will Receive New Data And An Update Of The European Central Bank's Forecasts, Which Will Allow US To Refine Our Assessment Of The Euro Area's Growth Momentum And Inflation Dynamics

Share

Czech Industrial Output At 3.8% In December

Share

Slovak Foreign Trade Deficit Of 162.7 Million Euros In December

Share

Ukraine Foreign Currency Reserves At $57.7 Billion As Of Feb 1

Share

Europe's STOXX Index Down 0.2%, Euro Zone Blue Chips Index Down 0.08%

Share

France's CAC 40 Down 0.02%, Spain's IBEX Down 0.51%

Share

Britain's FTSE 100 Down 0.45%

Share

Shanghai Rubber Warehouse Stocks Down 60 Tons

Share

Shanghai Nickel Warehouse Stocks Up 2061 Tons

Share

Shanghai Tin Warehouse Stocks Down 1718 Tons

Share

Stats Office - Austrian January Wholesale Prices +0.4% Year-On-Year

Share

Shanghai Lead Warehouse Stocks Up 17240 Tons

Share

Swiss National Bank Forex Reserves Revised To Chf 725358 Million At End Of December - SNB

Share

Spain's December Industrial Output Falls 0.3% Year-On-Year

Share

Swiss January Unadj Jobless Rate At 3.2% (Versus 3.1% In Previous Month)

Share

Swiss January Adj Jobless Rate At 2.9% (Versus 3.0% In Previous Month)

Share

Shanghai Zinc Warehouse Stocks Up 5535 Tons

TIME
ACT
FCST
PREV
U.K. Benchmark Interest Rate

A:--

F: --

P: --

MPC Rate Statement
U.S. Challenger Job Cuts (Jan)

A:--

F: --

P: --

U.S. Challenger Job Cuts MoM (Jan)

A:--

F: --

P: --

U.S. Challenger Job Cuts YoY (Jan)

A:--

F: --

P: --

Bank of England Governor Bailey held a press conference on monetary policy.
Euro Zone ECB Marginal Lending Rate

A:--

F: --

P: --

Euro Zone ECB Deposit Rate

A:--

F: --

P: --

Euro Zone ECB Main Refinancing Rate

A:--

F: --

P: --

ECB Monetary Policy Statement
U.S. Weekly Initial Jobless Claims (SA)

A:--

F: --

P: --

U.S. Initial Jobless Claims 4-Week Avg. (SA)

A:--

F: --

P: --

U.S. Weekly Continued Jobless Claims (SA)

A:--

F: --

P: --
ECB Press Conference
U.S. JOLTS Job Openings (SA) (Dec)

A:--

F: --

P: --
U.S. EIA Weekly Natural Gas Stocks Change

A:--

F: --

P: --

BOC Gov Macklem Speaks
Mexico Policy Interest Rate

A:--

F: --

P: --

U.S. Weekly Treasuries Held by Foreign Central Banks

A:--

F: --

P: --

Reserve Bank of Australia Governor Bullock testified before Parliament.
Japan Foreign Exchange Reserves (Jan)

A:--

F: --

P: --

India Benchmark Interest Rate

A:--

F: --

P: --

India Cash Reserve Ratio

A:--

F: --

P: --

India Repo Rate

A:--

F: --

P: --

India Reverse Repo Rate

A:--

F: --

P: --

Japan Leading Indicators Prelim (Dec)

A:--

F: --

P: --

Germany Industrial Output MoM (SA) (Dec)

A:--

F: --

P: --
Germany Exports MoM (SA) (Dec)

A:--

F: --

P: --

U.K. Halifax House Price Index YoY (SA) (Jan)

A:--

F: --

P: --
U.K. Halifax House Price Index MoM (SA) (Jan)

A:--

F: --

P: --
France Trade Balance (SA) (Dec)

A:--

F: --

P: --
Canada Leading Index MoM (Jan)

--

F: --

P: --

India Deposit Gowth YoY

--

F: --

P: --

Canada Employment (SA) (Jan)

--

F: --

P: --
Canada Full-time Employment (SA) (Jan)

--

F: --

P: --
Canada Part-Time Employment (SA) (Jan)

--

F: --

P: --
Canada Unemployment Rate (SA) (Jan)

--

F: --

P: --

Canada Labor Force Participation Rate (SA) (Jan)

--

F: --

P: --

Due to the previous government shutdown, the release date of the US January non-farm payroll report has been changed to February 11.
Canada Ivey PMI (Not SA) (Jan)

--

F: --

P: --

Canada Ivey PMI (SA) (Jan)

--

F: --

P: --

U.S. 5-10 Year-Ahead Inflation Expectations (Feb)

--

F: --

P: --

U.S. UMich Consumer Sentiment Index Prelim (Feb)

--

F: --

P: --

U.S. UMich 1-Year-Ahead Inflation Expectations Prelim (Feb)

--

F: --

P: --

U.S. UMich 5-Year-Ahead Inflation Expectations Prelim YoY (Feb)

--

F: --

P: --

U.S. UMich Current Economic Conditions Index Prelim (Feb)

--

F: --

P: --

U.S. UMich Consumer Expectations Index Prelim (Feb)

--

F: --

P: --

China, Mainland Foreign Exchange Reserves (Jan)

--

F: --

P: --

Russia Retail Sales YoY (Dec)

--

F: --

P: --

Russia Unemployment Rate (Dec)

--

F: --

P: --

Russia Quarterly GDP Prelim YoY (Q1)

--

F: --

P: --

U.S. Weekly Total Oil Rig Count

--

F: --

P: --

U.S. Weekly Total Rig Count

--

F: --

P: --

U.S. Consumer Credit (SA) (Dec)

--

F: --

P: --

Japan Wages MoM (Dec)

--

F: --

P: --

Japan Trade Balance (Customs Data) (SA) (Dec)

--

F: --

P: --

Japan Trade Balance (Dec)

--

F: --

P: --

Euro Zone Sentix Investor Confidence Index (Feb)

--

F: --

P: --

Mexico CPI YoY (Jan)

--

F: --

P: --

Mexico 12-Month Inflation (CPI) (Jan)

--

F: --

P: --

Mexico PPI YoY (Jan)

--

F: --

P: --

Q&A with Experts
    • All
    • Chatrooms
    • Groups
    • Friends
    Connecting
    .
    .
    .
    Type here...
    Add Symbol or Code

      No matching data

      All
      Trump Updates
      Recommend
      Stocks
      Cryptocurrencies
      Central Banks
      Featured News
      • All
      • Russia-Ukraine Conflict
      • Middle East Flashpoint
      • All
      • Russia-Ukraine Conflict
      • Middle East Flashpoint
      Search
      Products

      Charts Free Forever

      Chats Q&A with Experts
      Screeners Economic Calendar Data Tools
      Membership Features
      Data Warehouse Market Trends Institutional Data Policy Rates Macro

      Market Trends

      Market Sentiment Order Book Forex Correlations

      Top Indicators

      Charts Free Forever
      Markets

      News

      News Analysis 24/7 Columns Education
      From Institutions From Analysts
      Topics Columnists

      Latest Views

      Latest Views

      Trending Topics

      Top Columnists

      Latest Update

      Signals

      Copy Rankings Latest Signals Become a signal provider AI Rating
      Contests
      Brokers

      Overview Brokers Assessment Rankings Regulators News Claims
      Broker listing Forex Brokers Comparison Tool Live Spread Comparison Scam
      Q&A Complaint Scam Alert Videos Tips to Detect Scam
      More

      Business
      Events
      Careers About Us Advertising Help Center

      White Label

      Broker API

      Data API

      Web Plug-ins

      Affiliate Program

      Awards Institution Evaluation IB Seminar Salon Event Exhibition
      Vietnam Thailand Singapore Dubai
      Fans Party Investment Sharing Session
      FastBull Summit BrokersView Expo
      Recent Searches
        Top Searches
          Markets
          News
          Analysis
          User
          24/7
          Economic Calendar
          Education
          Data
          • Names
          • Latest
          • Prev

          View All

          No data

          Scan to Download

          Faster Charts, Chat Faster!

          Download App
          English
          • English
          • Español
          • العربية
          • Bahasa Indonesia
          • Bahasa Melayu
          • Tiếng Việt
          • ภาษาไทย
          • Français
          • Italiano
          • Türkçe
          • Русский язык
          • 简中
          • 繁中
          Open Account
          Search
          Products
          Charts Free Forever
          Markets
          News
          Signals

          Copy Rankings Latest Signals Become a signal provider AI Rating
          Contests
          Brokers

          Overview Brokers Assessment Rankings Regulators News Claims
          Broker listing Forex Brokers Comparison Tool Live Spread Comparison Scam
          Q&A Complaint Scam Alert Videos Tips to Detect Scam
          More

          Business
          Events
          Careers About Us Advertising Help Center

          White Label

          Broker API

          Data API

          Web Plug-ins

          Affiliate Program

          Awards Institution Evaluation IB Seminar Salon Event Exhibition
          Vietnam Thailand Singapore Dubai
          Fans Party Investment Sharing Session
          FastBull Summit BrokersView Expo

          Azenta (AZTA) To Report Earnings Tomorrow: Here Is What To Expect

          Stock Story
          Azenta
          -2.25%

          Life sciences company Azenta will be announcing earnings results this Wednesday before the bell. Here’s what you need to know.

          Azenta beat analysts’ revenue expectations by 1.6% last quarter, reporting revenues of $159.2 million, up 5.5% year on year. It was a slower quarter for the company, with EPS in line with analysts’ estimates.

          Is Azenta a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.

          This quarter, analysts are expecting Azenta’s revenue to be flat year on year at $147 million, slowing from the 4.1% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.13 per share.

          Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Azenta has missed Wall Street’s revenue estimates five times over the last two years.

          Looking at Azenta’s peers in the life sciences tools & services segment, some have already reported their Q4 results, giving us a hint as to what we can expect. Thermo Fisher delivered year-on-year revenue growth of 7.2%, beating analysts’ expectations by 2.1%, and Revvity reported revenues up 5.8%, topping estimates by 1.1%. Thermo Fisher traded down 4.8% following the results.

          Read our full analysis of Thermo Fisher’s results here and Revvity’s results here.

          Investors in the life sciences tools & services segment have had steady hands going into earnings, with share prices flat over the last month. Azenta is up 5.1% during the same time and is heading into earnings with an average analyst price target of $43.50 (compared to the current share price of $37.61).

          Risk Warnings and Disclaimers
          You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.
          Add to Favorites
          Share

          Why Are Azenta (AZTA) Shares Soaring Today

          Stock Story
          Azenta
          -2.25%

          What Happened?

          Shares of life sciences company Azenta jumped 7.3% in the afternoon session after Evercore ISI Group upgraded the company's rating to "Outperform" from "In-Line" and raised its price target. 

          The firm's analyst, Vijay Kumar, increased the price target on the stock to $50.00 from a previous target of $34.00. This represented a substantial change of over 47%. Such a significant upgrade and price target hike from a financial analyst often signals strong confidence in a company's future prospects, which can attract investor interest and drive up the share price.

          What Is The Market Telling Us

          Azenta’s shares are extremely volatile and have had 30 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business.

          The biggest move we wrote about over the last year was 5 months ago when the stock dropped 16.3% on the news that the company announced mixed third-quarter financial results, where a failure to meet revenue targets overshadowed a profit beat. 

          The company disclosed revenue of approximately $144 million, which fell short of analyst projections. This result was flat compared to the same period last year and reflected a 2% organic decline. The shortfall stemmed from weakness in its Sample Management Solutions division, where revenue dropped by 4%. In contrast, Azenta posted adjusted earnings per share of $0.19, which exceeded expectations. Despite the disappointing sales figures, the company maintained its financial guidance for the full fiscal year, but investors focused on the revenue miss.

          Azenta is up 6.9% since the beginning of the year, but at $35.70 per share, it is still trading 34.8% below its 52-week high of $54.75 from January 2025. Investors who bought $1,000 worth of Azenta’s shares 5 years ago would now be looking at an investment worth $529.28.

          Risk Warnings and Disclaimers
          You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.
          Add to Favorites
          Share

          Azenta (AZTA): Buy, Sell, or Hold Post Q3 Earnings?

          Stock Story
          Azenta
          -2.25%

          Azenta trades at $34.56 and has moved in lockstep with the market. Its shares have returned 12.3% over the last six months while the S&P 500 has gained 11.7%.

          Why Do We Think Azenta Will Underperform?

          We're cautious about Azenta. Here are three reasons you should be careful with AZTA and a stock we'd rather own.

          1. Revenue Spiraling Downwards

          A company’s long-term performance is an indicator of its overall quality. Even a bad business can shine for one or two quarters, but a top-tier one grows for years. Over the last five years, Azenta’s demand was weak and its revenue declined by 4.8% per year. This was below our standards and is a sign of poor business quality.

          2. EPS Trending Down

          Analyzing the long-term change in earnings per share (EPS) shows whether a company's incremental sales were profitable – for example, revenue could be inflated through excessive spending on advertising and promotions.

          Sadly for Azenta, its EPS declined by 18.8% annually over the last five years, more than its revenue. This tells us the company struggled because its fixed cost base made it difficult to adjust to shrinking demand.

          3. Cash Burn Ignites Concerns

          If you’ve followed StockStory for a while, you know we emphasize free cash flow. Why, you ask? We believe that in the end, cash is king, and you can’t use accounting profits to pay the bills.

          While Azenta’s free cash flow broke even this quarter, the broader story hasn’t been so clean. Azenta’s demanding reinvestments have consumed many resources over the last five years, contributing to an average free cash flow margin of negative 14.2%. This means it lit $14.20 of cash on fire for every $100 in revenue.

          Final Judgment

          Azenta doesn’t pass our quality test. That said, the stock currently trades at 44× forward P/E (or $34.56 per share). This valuation tells us a lot of optimism is priced in - you can find more timely opportunities elsewhere. Let us point you toward a top digital advertising platform riding the creator economy.

          Risk Warnings and Disclaimers
          You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.
          Add to Favorites
          Share

          Azenta Is Maintained at Buy by Needham

          Dow Jones Newswires
          Azenta
          -2.25%

          (12:16 GMT) Azenta Price Target Raised to $44.00/Share From $42.00 by Needham

          Risk Warnings and Disclaimers
          You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.
          Add to Favorites
          Share

          Azenta stock rises as company unveils $250 million share buyback

          Investing.com
          NVIDIA
          -1.33%
          Azenta
          -2.25%
          Alphabet-A
          -0.54%
          Meta Platforms
          +0.18%
          Advanced Micro Devices
          -3.84%

          Investing.com -- Azenta Inc (NASDAQ:AZTA) stock climbed 6.7% on Wednesday after the company announced a new $250 million share repurchase program approved by its Board of Directors.

          The buyback plan, which began on December 9, 2025, will run through December 31, 2028, unless extended or terminated earlier by the Board. The company said the program is designed to enhance shareholder value and capitalize on what it views as undervaluation of its stock.

          Under the program, Azenta may repurchase shares through open market transactions, privately negotiated deals, or other methods compliant with Securities Exchange Act rules. The company emphasized that the authorization doesn’t obligate it to repurchase any specific dollar amount or number of shares.

          John Marotta, President and CEO of Azenta, described the share repurchase as part of the company’s broader capital allocation strategy, which includes "driving productivity and gross margin improvement, accelerating organic growth, pursuing strategic M&A with discipline, and returning capital to shareholders."

          The company noted that repurchases may be commenced, suspended, modified, or discontinued at any time without prior notice, depending on market conditions, business considerations, and legal requirements.

          This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

          Risk Warnings and Disclaimers
          You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.
          Add to Favorites
          Share

          AZTA: Growth and margin expansion to 2028 driven by biorepository scale, gene synthesis, and operational rigor

          Quartr
          Azenta
          -2.25%

          A decentralized structure and operational excellence are driving growth, with biorepositories and gene synthesis regionalization as key initiatives. Financial targets include doubling EBITDA and reaching $700M-$750M revenue by 2028, supported by disciplined capital allocation and a robust M&A pipeline.

          Based on Azenta, Inc. [AZTA] Investor Day 2025 Audio Transcript — Dec. 10 2025

          Disclaimer
          This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
          Risk Warnings and Disclaimers
          You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.
          Add to Favorites
          Share

          AZTA: Targeting $700–$750M revenue and double EBITDA by 2028 through growth, automation, and efficiency

          Quartr
          Azenta
          -2.25%

          A decentralized structure and operational excellence are driving above-market growth, margin expansion, and disciplined capital allocation. Key initiatives include scaling BioRepositories, regionalizing gene synthesis, and investing in automation, with a goal to double EBITDA and reach $700–$750 million in revenue by 2028.

          Based on Azenta, Inc. [AZTA] Investor Day 2025 Audio Transcript — Dec. 10 2025

          Disclaimer
          This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
          Risk Warnings and Disclaimers
          You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.
          Add to Favorites
          Share
          FastBull
          Copyright © 2026 FastBull Ltd

          728 RM B 7/F GEE LOK IND BLDG NO 34 HUNG TO RD KWUN TONG KLN HONG KONG

          TelegramInstagramTwitterfacebooklinkedin
          App Store Google Play Google Play
          Products
          Charts

          Chats

          Q&A with Experts
          Screeners
          Economic Calendar
          Data
          Tools
          Membership
          Features
          Function
          Markets
          Copy Trading
          Latest Signals
          Contests
          News
          Analysis
          24/7
          Columns
          Education
          Company
          Careers
          About Us
          Contact Us
          Advertising
          Help Center
          Feedback
          User Agreement
          Privacy Policy
          Personal Information Protection Statement
          Business

          White Label

          Broker API

          Data API

          Web Plug-ins

          Poster Maker

          Affiliate Program

          Risk Disclosure

          The risk of loss in trading financial instruments such as stocks, FX, commodities, futures, bonds, ETFs and crypto can be substantial. You may sustain a total loss of the funds that you deposit with your broker. Therefore, you should carefully consider whether such trading is suitable for you in light of your circumstances and financial resources.

          No decision to invest should be made without thoroughly conducting due diligence by yourself or consulting with your financial advisors. Our web content might not suit you since we don't know your financial conditions and investment needs. Our financial information might have latency or contain inaccuracy, so you should be fully responsible for any of your trading and investment decisions. The company will not be responsible for your capital loss.

          Without getting permission from the website, you are not allowed to copy the website's graphics, texts, or trademarks. Intellectual property rights in the content or data incorporated into this website belong to its providers and exchange merchants.

          Not Logged In

          Log in to access more features

          Connect Broker
          Become a signal provider
          Help Center
          Customer Service
          Dark Mode
          Price Up/Down Colors

          Log In

          Sign Up

          Position
          Layout
          Fullscreen
          Default to Chart
          The chart page opens by default when you visit fastbull.com